DEC 02, 2019 5:41 PM PST

Self-renewing blood stem cells give hope for blood disease treatments

New research details how activating a certain protein may be the key to getting hematopoietic stem cells (HSCs) to self-renew. The research comes from scientists at UCLA and was published recently in Nature. Its findings may open doorways for leukemia treatment, as well as other blood diseases.

HSCs are blood stem cells found in the bone marrow that make blood by differentiating into cells like red blood cells, T and B lymphocytes, and white blood cells. HSCs play an infinitely important role in making billions of new blood cells in the human body every day.

But for people with blood diseases, HSCs are necessary to make new blood cells, a demand which has typically been met with a supply of bone marrow. However, due to the array of difficulties that come along with bone marrow transplants, some researchers have been looking into using cultured HSCs to replace bone marrow transplants. Yet, they keep on getting stumped because HSCs lose their capacity for self-renewal in cultures soon after being removed from bone marrow.

"Although we've learned a lot about the biology of these cells over the years, one key challenge has remained: making [HSCs] self-renew in the lab. We have to overcome this obstacle to move the field forward," explains senior study author Hanna K. A. Mikkola, a professor of molecular, cell, and developmental biology at UCLA.

That’s why this study’s finding of a protein called MLLT3 is so noteworthy. Mikkola and her team found that manipulating MLLT3 resulted in a "more than 12-fold expansion of transplantable" HSCs. "If we think about the amount of blood stem cells needed to treat a patient, that's a significant number," commented Mikkola. The researchers plan to continue working on their process with MLLT3 in order to move from animal trials to human trials.

Sources: Nature, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 02, 2020
Genetics & Genomics
JAN 02, 2020
Mysterious Extrachromosomal DNA is Linked to Childhood Cancer
Scientists are learning more about an unusual kind of DNA that's separate from a cell's genomic DNA....
JAN 18, 2020
JAN 18, 2020
What's the deal with turmeric?
Have you fallen for the turmeric craze? That little orange root that yellows your fingers when you peel it has become very popular recently for its medicin...
JAN 20, 2020
JAN 20, 2020
Ovarian Cancer Protein Accelerates Alzheimer's Neurodegeneration
Around 21,000 people in the US are diagnosed with ovarian cancer every year, while an estimated 5.8 million Americans have Alzheimer’s. Now, research...
FEB 09, 2020
FEB 09, 2020
Investigating the Links Between Viruses and Cancer
The Pan-Cancer Analysis of Whole Genomes (PCAWG) has brought over 1,300 scientists together to gain new insights into the genetics of cancer....
FEB 19, 2020
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diag...
Loading Comments...